Clinical trials research potential new treatments for people living with MS. Nearly 1 million people in the U.S. have been diagnosed with MS. Symptoms vary from person to person, but most commonly include fatigue and difficulty walking. Relapsing-remitting MS (RRMS) is the most common disease course approximately 85% of people with MS are first diagnosed with this type.


https://antidote.me/prescreener/g/re...aign=TMRRMS975